Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...

The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

A group of Penn researchers found that a common blood pressure medicine can be used to prevent brain cancer cells from ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

A family was devastated after a baby's "ordinary cold" turned out to be a rare blood cancer. Four-month-old Melody developed ...

TEXAS – A new wave of blood tests is changing how doctors detect cancer. These tests can find signs of cancer early, ...

The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer screening test works.

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

As researchers continue to investigate hydralazine's capabilities, the goal is to develop more targeted treatments that ...

"Hearing those words was like a stabbing pain in my heart," baby Melody's mom said of the moment the family learned of the ...

Among 200 eligible patients with a life expectancy of 6 months or less, access to palliative blood transfusions was of greatest importance when considering enrollment in hospice care, reported Oreofe ...